scholarly article | Q13442814 |
P50 | author | E Agarwal | Q55319427 |
Dario C Altieri | Q98158352 | ||
P2093 | author name string | Yuan Wang | |
David W Speicher | |||
Jagadish C Ghosh | |||
Jae Ho Seo | |||
Hsin-Yao Tang | |||
Andrew V Kossenkov | |||
P2860 | cites work | Landscape of the mitochondrial Hsp90 metabolome in tumours | Q37067115 |
Mitochondrial dynamics regulates migration and invasion of breast cancer cells | Q37548419 | ||
The mitochondrial UPR - protecting organelle protein homeostasis | Q37806885 | ||
Dynamics of the ClpP serine protease: a model for self-compartmentalized proteases | Q38219190 | ||
Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. | Q38482230 | ||
Proteostasis control by the unfolded protein response | Q38540196 | ||
Emerging role of Lon protease as a master regulator of mitochondrial functions. | Q38795089 | ||
AKT/PKB Signaling: Navigating the Network | Q39255027 | ||
A LON-ClpP Proteolytic Axis Degrades Complex I to Extinguish ROS Production in Depolarized Mitochondria. | Q39675106 | ||
Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. | Q40063505 | ||
LON is the master protease that protects against protein aggregation in human mitochondria through direct degradation of misfolded proteins | Q41811406 | ||
The Akt isoforms are present at distinct subcellular locations | Q43216821 | ||
AKT-mTOR signaling modulates the dynamics of IRE1 RNAse activity by regulating ER-mitochondria contacts. | Q47126627 | ||
Mitochondrial Lon Protease and Cancer | Q47361687 | ||
Targeting the PI3K pathway in cancer: are we making headway? | Q52672314 | ||
Mitochondria and Cancer. | Q53198693 | ||
ATP-Dependent Lon Protease Controls Tumor Bioenergetics by Reprogramming Mitochondrial Activity | Q57082590 | ||
Mitochondria in cancer metabolism, an organelle whose time has come? | Q88882190 | ||
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growth | Q90028792 | ||
LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells | Q90431965 | ||
HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells | Q24302194 | ||
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? | Q26852282 | ||
PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion | Q27324467 | ||
Crystal structure of Lon protease: molecular architecture of gated entry to a sequestered degradation chamber | Q27664441 | ||
Mitochondrial Lon protease in human disease and aging: Including an etiologic classification of Lon-related diseases and disorders | Q28071866 | ||
The Warburg effect: 80 years on | Q28076125 | ||
Adapting proteostasis for disease intervention | Q28131818 | ||
Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming | Q28771755 | ||
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification | Q29547200 | ||
Molecular chaperones in protein folding and proteostasis | Q29547715 | ||
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress | Q29615495 | ||
Modulation of oxidative stress as an anticancer strategy | Q29615707 | ||
Mitochondria and cancer | Q29616610 | ||
A neuronal network of mitochondrial dynamics regulates metastasis | Q30833071 | ||
Organismal proteostasis: role of cell-nonautonomous regulation and transcellular chaperone signaling | Q33917420 | ||
Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer. | Q34493828 | ||
Turnover of mitochondrial steroidogenic acute regulatory (StAR) protein by Lon protease: the unexpected effect of proteasome inhibitors. | Q34580480 | ||
Distinct quaternary structures of the AAA+ Lon protease control substrate degradation. | Q34651849 | ||
Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies | Q35152946 | ||
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia. | Q35708954 | ||
Regulators of mitochondrial dynamics in cancer | Q35929111 | ||
Adaptive mitochondrial reprogramming and resistance to PI3K therapy. | Q36047440 | ||
The Mitochondrial Unfoldase-Peptidase Complex ClpXP Controls Bioenergetics Stress and Metastasis. | Q36070569 | ||
Oxidative stress inhibits distant metastasis by human melanoma cells | Q36277720 | ||
Mitochondrial Lon regulates apoptosis through the association with Hsp60-mtHsp70 complex. | Q36347232 | ||
MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins | Q36434534 | ||
Slicing a protease: structural features of the ATP-dependent Lon proteases gleaned from investigations of isolated domains | Q36458536 | ||
Mitochondrial localization and the persistent migration of epithelial cancer cells | Q36824448 | ||
Hsp90 regulation of mitochondrial protein folding: from organelle integrity to cellular homeostasis | Q37056146 | ||
P433 | issue | 43 | |
P304 | page(s) | 6926-6939 | |
P577 | publication date | 2019-08-12 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Akt phosphorylation of mitochondrial Lonp1 protease enables oxidative metabolism and advanced tumor traits | |
P478 | volume | 38 |